Study ties Paxlovid to lower COVID-19 hospitalization rate
Adult US COVID-19 patients who received the antiviral drug Paxlovid within 5 days after diagnosis had a 51% lower hospitalization...
Adult US COVID-19 patients who received the antiviral drug Paxlovid within 5 days after diagnosis had a 51% lower hospitalization...
A new study out of Denmark suggests COVID-19 vaccines offer good protection against reinfection in people who had already acquired...
This holiday season is a difficult reminder for Liz Huerta. “It’s starting to bring up all these emotions again,” she...
Welcome to Foreign Policy’s China Brief. The highlights this week: China takes one step forward and two steps back on its COVID-19...
The Hawaiʻi State Department of Health reported 1,169 new COVID-19 cases for the week of Nov. 17-23, 2022. This is well below the most...
A US study of the vaccine effectiveness (VE) of the new bivalent mRNA COVID-19 boosters estimates that they confer 28%...
WASHINGTON, Nov 23 (Reuters) - The International Monetary Fund urged China on Wednesday to boost COVID-19 vaccination rates and give...
WASHINGTON — Dr. Anthony Fauci was quizzed for several hours Wednesday by the Republican attorneys general of two states as...
Reported COVID-19 cases in Arizona rose again last week and the percentage of tests returning positive for the virus climbed to...
CLEVELAND, Ohio — Ohio dipped below the benchmark of 10,000 COVID-19 cases this week, dropping from 10,170 last week to...